Related Experiment Video
Updated: May 23, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes
Sunil B Kumaraswamy1, Adam Linder, Per Åkesson
1Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Skåne University Hospital, Entrance 46, Malmö, SE-20502, Sweden.
Introduction:
Apolipoprotein M (apoM) is present in 5% of high-density lipoprotein (HDL) particles in plasma. It is a carrier of sphingosine-1-phosphate (S1P), which is important for vascular barrier protection. The aim was to determine the plasma concentrations of apoM during sepsis and systemic inflammatory response syndrome (SIRS) and correlate them to levels of apolipoprotein A-I (apoA1), apolipoprotein B (apoB), HDL-, and low-density lipoprotein (LDL)-cholesterol.
Methods:
Plasma samples from patients with (1), severe sepsis with shock (n = 26); (2), severe sepsis without shock (n = 44); (3), sepsis (n = 100); (4), infections without SIRS (n = 43); and (5) SIRS without infection (n = 20) were analyzed. The concentrations of apoM, apoA1, and apoB were measured with enzyme-linked immunosorbent assays (ELISAs). Total, HDL-, and LDL-cholesterol concentrations were measured with a commercial HDL/LDL cholesterol test.
Results:
ApoM concentrations correlated negatively to acute-phase markers. Thus, apoM behaved as a negative acute-phase protein. Decreased values were observed in all patient groups (P < 0.0001), with the most drastic decreases observed in the severely sick patients. ApoM levels correlated strongly to those of apoA1, apoB, HDL, and LDL cholesterol. The HDL and LDL cholesterol levels were low in all patient groups, as compared with controls (P < 0.0001), in particular, HDL cholesterol. ApoA1 and apoB concentrations were low only in the more severely affected patients.
Conclusions:
During sepsis and SIRS, the plasma concentrations of apoM decrease dramatically, the degree of decrease reflecting the severity of the disease. As a carrier for barrier-protective S1P in HDL, the decrease in apoM could contribute to the increased vascular leakage observed in sepsis and SIRS.
Insights
Plasma concentrations of apolipoprotein M (apoM) significantly decrease during sepsis and systemic inflammatory response syndrome (SIRS). Lower apoM levels correlate with disease severity, potentially contributing to vascular leakage.
Area of Science:
- Biochemistry
- Clinical Medicine
- Immunology
Background:
- Apolipoprotein M (apoM) is a protein found in high-density lipoprotein (HDL) particles.
- It serves as a carrier for sphingosine-1-phosphate (S1P), crucial for maintaining vascular barrier integrity.
- Understanding apoM levels in inflammatory conditions is vital for assessing disease progression and potential complications.
Purpose of the Study:
- To quantify plasma concentrations of apoM in patients with sepsis and SIRS.
- To investigate the correlation between apoM levels and other biomarkers such as apolipoprotein A-I (apoA1), apolipoprotein B (apoB), and cholesterol levels (HDL, LDL).
- To determine if apoM acts as an acute-phase reactant in these conditions.
Main Methods:
- Plasma samples were collected from distinct patient groups: severe sepsis with shock, severe sepsis without shock, sepsis, infections without SIRS, and SIRS without infection.
- Concentrations of apoM, apoA1, and apoB were measured using enzyme-linked immunosorbent assays (ELISAs).
- Total, HDL-, and LDL-cholesterol levels were determined using a commercial assay.
Main Results:
- ApoM concentrations showed a negative correlation with acute-phase markers, indicating it functions as a negative acute-phase protein.
- Significantly decreased apoM levels were observed across all patient groups compared to controls, with the most pronounced reduction in severe sepsis.
- ApoM levels strongly correlated with apoA1, apoB, HDL-cholesterol, and LDL-cholesterol levels, which were also generally reduced in patient groups.
Conclusions:
- Plasma apoM concentrations decrease dramatically during sepsis and SIRS, with the extent of reduction reflecting disease severity.
- The diminished levels of apoM, a carrier of the vascular-protective S1P, may contribute to the increased vascular permeability characteristic of sepsis and SIRS.
- ApoM's behavior as a negative acute-phase protein warrants further investigation in the context of inflammatory diseases.
More Related Videos
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Nephrotic Syndrome I : Introduction
Acute Pancreatitis II: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
